Solferino Associés advises Medasys (company listed on Euronext Paris) in the context of its capital increase
This capital increase amounting to € 10 millions aimed at partially refinancing two major acquisitions carried out in 2018:
- 100% stake in Infologic-Santé, leading publisher in France in Pathology and Genetics solutions, which equips more than 75% of hospitals and private laboratories with its solutions, for a total of € 6 millions; and
- 100% stake in DL Santé, a medical software publisher mainly positioned in the segment of private medical biology laboratories, for a total of € 10.5 millions.
The success of this capital increase was guaranteed by Dedalus S.p.A, after this capital increase, 81.83% of the capital and 82.01% of the voting rights of Medasys.
Dedalus S.p.A and Medasys were advised by Solferino Associés (Fouad Bellaaroussi, Marie-Estelle Colin and Camille Chastagner).